Aperio Group’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-197,384
Closed -$1.92M 2278
2017
Q2
$1.92M Buy
197,384
+160
+0.1% +$1.61K 0.01% 927
2017
Q1
$2.09M Hold
197,224
0.01% 856
2016
Q4
$1.76M Buy
197,224
+206
+0.1% +$2.08K 0.01% 871
2016
Q3
$2.38M Buy
197,018
+293
+0.1% +$3.95K 0.02% 783
2016
Q2
$2.56M Sell
196,725
-138
-0.1% -$1.28K 0.02% 715
2016
Q1
$1.09M Buy
196,863
+54,114
+38% +$286K 0.01% 1009
2015
Q4
$739K Buy
142,749
+138
+0.1% +$830 0.01% 1141
2015
Q3
$930K Buy
142,611
+3,407
+2% +$20.7K 0.01% 1005
2015
Q2
$874K Sell
139,204
-736
-0.5% -$4.35K 0.01% 1035
2015
Q1
$634K Buy
139,940
+129,551
+1,247% +$720K 0.01% 1149
2014
Q4
$52K Sell
10,389
-22,285
-68% -$117K ﹤0.01% 1855
2014
Q3
$199K Sell
32,674
-2,514
-7% -$21.5K ﹤0.01% 1609
2014
Q2
$305K Buy
35,188
+970
+3% +$8.38K ﹤0.01% 1389
2014
Q1
$340K Buy
+34,218
New +$321K ﹤0.01% 1536
2013
Q4
Hold
0
1703

Other funds holding SSRI

Aperio Group's SSRI Position: Q3 2017 in Review

Aperio Group sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 197,384 shares — an estimated $1.92M sold.

Aperio Group first reported a position in SSRI in Q1 2014 and held it in 14 quarters. The position peaked at $2.56M in Q2 2016. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

  • Aperio Group reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
  • Aperio Group sold 197,384 Silver Standard Resources shares in Q3 2017, an estimated $1.92M.
  • Aperio Group first reported a position in Silver Standard Resources in Q1 2014 and held it in 14 quarters.
  • Aperio Group's Silver Standard Resources position peaked at $2.56M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Aperio Group's 13F filing for Q3 2017, filed 25 Oct 2017.